Key account management Patients Pharma Prescription 
Clarity Engagement Solutions
NOVEMBER 9, 2020
Traditionally the pharma industry relied on the volume of prescriptions made. A primary challenge for pharma and bio-tech companies is how to identify the right stakeholders in the approval process. Pharma and bio-tech companies need to adopt more innovative market access tactics to succeed.
Clarity Engagement Solutions
NOVEMBER 9, 2020
Traditionally the pharma industry relied on the volume of prescriptions made. the evolving healthcare industry, pharma and bio-tech companies are now focusing on each component of market access: – Price. A primary challenge for pharma and bio-tech companies is how to identify the right stakeholders in the approval process.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 23, 2022
In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). Given the demand to deliver a steady stream of content to meet HCPs’ needs, pharma marketers must react, create, edit, and adapt quickly. And in 2023, these investments will hopefully pay off.
Quantified
APRIL 18, 2022
A global head of sales at a pharma company recently told me that “only 15% of our sales calls end in a positive outcome.”. In the context of a new medical innovation where there is a high unmet patient need, this means patients are not getting rapid access to medicines that can positively impact or even extend their lives.
Evolve Your Success
JANUARY 31, 2023
A lot of organizations that may have a sales model don’t probably follow the prescription that we deliver or the method that we deliver to them, which is why they contract us. I’m not going to be able to message you to change the way you manage a patient population. It’s rapport-building. It can be done.
Expert insights. Personalized for you.
91 
Let's personalize your content